Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?

Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?

Source: 
Motley Fool
snippet: 
  • Moderna is replacing Alexion Pharmaceuticals on the S&P 500 index.
  • The performances of stocks that have recently been added to the index don't help much in determining how Moderna's shares will perform.
  • The most important thing for Moderna right now is what happens with coronavirus variants of concern.